Ferroportin deficiency impairs manganese metabolism in flatiron mice

FASEB Journal

Volumn 29, Issue 7, 2015, Pages 2726-2733

  Seo, Young Ah ^a   Wessling Resnick, Marianne ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Hepcidin; Iron metabolism; Manganese transport

Indexed keywords

FERROPORTIN; MANGANESE; MANGANESE SUPEROXIDE DISMUTASE; CATION TRANSPORT PROTEIN; IRON; METAL TRANSPORTING PROTEIN 1; NEUROTOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE LEVEL; CONTROLLED STUDY; CYTOTOXICITY; FERROPORTIN DEFICIENCY; FLATIRON MOUSE; GENETIC MODEL; IRON METABOLISM; LIVER LEVEL; MANGANESE BLOOD LEVEL; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; ACTIVE TRANSPORT; ANIMAL; BIOLOGICAL MODEL; CELL LINE; DEFICIENCY; DOPAMINERGIC NERVE CELL; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; HOMEOSTASIS; HUMAN; INTESTINE ABSORPTION; METABOLISM; MISSENSE MUTATION; MUTANT MOUSE STRAIN;

MUS;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CATION TRANSPORT PROTEINS; CELL LINE; DOPAMINERGIC NEURONS; HEK293 CELLS; HOMEOSTASIS; HUMANS; INTESTINAL ABSORPTION; IRON; MANGANESE; MICE; MICE, MUTANT STRAINS; MODELS, ANIMAL; MODELS, GENETIC; MUTATION, MISSENSE; NEUROTOXINS;

EID: 84940117015     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-262592     Document Type: Article

References (64)

1. Golub, M. S., Hogrefe, C. E., Germann, S. L., Tran, T. T., Beard, J. L., Crinella, F. M., and Lonnerdal, B. (2005) Neurobehavioral evaluation of rhesus monkey infants fed cow's milk formula, soy formula, or soy formula with added manganese. Neurotoxicol. Teratol. 27, 615-627.
2. Erratum in Neurotoxicol. Teratol. 2012;34:220
3. Morello, M., Zatta, P., Zambenedetti, P., Martorana, A., D'Angelo, V., Melchiorri, G., Bernardi, G., and Sancesario, G. (2007) Manganese intoxication decreases the expression of manganoproteins in the rat basal ganglia: an immunohistochemical study. Brain Res. Bull. 74, 406-415
4. Aschner, M., Guilarte, T. R., Schneider, J. S., and Zheng, W. (2007) Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol. Appl. Pharmacol. 221, 131-147
5. Hong, J. S., Hung, C. R., Seth, P. K., Mason, G., and Bondy, S. C. (1984) Effect of manganese treatment on the levels of neurotransmitters, hormones, and neuropeptides: modulation by stress. Environ. Res. 34, 242-249
6. Yamada, M., Ohno, S., Okayasu, I., Okeda, R., Hatakeyama, S., Watanabe, H., Ushio, K., and Tsukagoshi, H. (1986) Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol. 70, 273-278
7. Lucchini, R., Bergamaschi, E., Smargiassi, A., Festa, D., and Apostoli, P. (1997) Motor function, olfactory threshold, and hematological indices in manganese-exposed ferroalloy workers. Environ. Res. 73, 175-180
8. Tran, T. T., Chowanadisai, W., Crinella, F. M., Chicz-DeMet, A., and Lönnerdal, B. (2002) Effect of high dietary manganese intake of neonatal rats on tissue mineral accumulation, striatal dopamine levels, and neurodevelopmental status. Neurotoxicology 23, 635-643
9. Mena, I., Horiuchi, K., Burke, K., and Cotzias, G. C. (1969) Chronic manganese poisoning. Individual susceptibility and absorption of iron. Neurology 19, 1000-1006
10. Sriram, K., Lin, G. X., Jefferson, A. M., Roberts, J. R., Chapman, R. S., Chen, B. T., Soukup, J. M., Ghio, A. J., and Antonini, J. M. (2010) Dopaminergic neurotoxicity following pulmonary exposure to manganese-containing welding fumes. Arch. Toxicol. 84, 521-540
11. Barbeau, A. (1984) Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias). Neurotoxicology 5, 13-35
12. Donaldson, J. (1987) The physiopathologic significance ofmanganese in brain: its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology 8, 451-462
13. Zayed, J., Gérin, M., Loranger, S., Sierra, P., Bégin, D., and Kennedy, G. (1994) Occupational and environmental exposure of garage workers and taxi drivers to airborne manganese arising from the use of methylcyclopentadienyl manganese tricarbonyl in unleaded gasoline. Am. Ind. Hyg. Assoc. J. 55, 53-58
14. Frumkin, H., and Solomon, G. (1997) Manganese in the U. S. gasoline supply. Am. J. Ind. Med. 31, 107-115
15. Prahalad, A. K., Soukup, J. M., Inmon, J., Willis, R., Ghio, A. J., Becker, S., and Gallagher, J. E. (1999) Ambient air particles: effects on cellular oxidant radical generation in relation to particulate elemental chemistry. Toxicol. Appl. Pharmacol. 158, 81-91
16. Quadri, M., Federico, A., Zhao, T., Breedveld, G. J., Battisti, C., Delnooz, C., Severijnen, L. A., Di Toro Mammarella, L., Mignarri, A., Monti, L., Sanna, A., Lu, P., Punzo, F., Cossu, G., Willemsen, R., Rasi, F., Oostra, B. A., van de Warrenburg, B. P., and Bonifati, V. (2012) Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. Am. J. Hum. Genet. 90, 467-477
17. Tuschl, K., Clayton, P. T., Gospe, S. M., Jr., Gulab, S., Ibrahim, S., Singhi, P., Aulakh, R., Ribeiro, R. T., Barsottini, O. G., Zaki, M. S., Del Rosario, M. L., Dyack, S., Price, V., Rideout, A., Gordon, K., Wevers, R. A., Chong, W. K., and Mills, P. B. (2012) Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. Am. J. Hum. Genet. 90, 457-466
18. DeWitt, M. R., Chen, P., and Aschner, M. (2013) Manganese efflux in Parkinsonism: insights from newly characterized SLC30A10 mutations. Biochem. Biophys. Res. Commun. 432, 1-4
19. Leyva-Illades, D., Chen, P., Zogzas, C. E., Hutchens, S., Mercado, J. M., Swaim, C. D., Morrisett, R. A., Bowman, A. B., Aschner, M., and Mukhopadhyay, S. (2014) SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its intracellular trafficking and efflux activity. J. Neurosci. 34, 14079-14095
20. Fitsanakis, V. A., Zhang, N., Garcia, S., and Aschner, M. (2010) Manganese (Mn) and iron (Fe): interdependency of transport and regulation. Neurotox. Res. 18, 124-131
21. Chua, A. C., and Morgan, E. H. (1997) Manganese metabolism is impaired in the Belgrade laboratory rat. J. Comp. Physiol. B 167, 361-369
22. Thompson, K., Molina, R. M., Donaghey, T., Schwob, J. E., Brain, J. D., and Wessling-Resnick, M. (2007) Olfactory uptake of manganese requires DMT1 and is enhanced by anemia. FASEB J. 21, 223-230
23. Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., Law, T. C., Brugnara, C., Lux, S. E., Pinkus, G. S., Pinkus, J. L., Kingsley, P. D., Palis, J., Fleming, M. D., Andrews, N. C., and Zon, L. I. (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776-781
24. McKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzaneh, F., Hediger, M. A., Hentze, M. W., and Simpson, R. J. (2000) A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 5, 299-309
25. Madejczyk, M. S., and Ballatori, N. (2012) The iron transporter ferroportin can also function as a manganese exporter. Biochim. Biophys. Acta 1818, 651-657
26. Mitchell, C. J., Shawki, A., Ganz, T., Nemeth, E., and Mackenzie, B. (2014) Functional properties of human ferroportin, a cellular iron exporter reactive also with cobalt and zinc. Am. J. Physiol. Cell Physiol. 306, C450-C459
27. Yin, Z., Jiang, H., Lee, E. S., Ni, M., Erikson, K. M., Milatovic, D., Bowman, A. B., and Aschner, M. (2010) Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation. J. Neurochem. 112, 1190-1198
28. Park, B. Y., and Chung, J. (2008) Effects of various metal ions on the gene expression of iron exporter ferroportin-1 in J774 macrophages. Nutr. Res. Pract. 2, 317-321
29. Donovan, A., Lima, C. A., Pinkus, J. L., Pinkus, G. S., Zon, L. I., Robine, S., and Andrews, N. C. (2005) The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 1, 191-200
30. Zohn, I. E., De Domenico, I., Pollock, A., Ward, D. M., Goodman, J. F., Liang, X., Sanchez, A. J., Niswander, L., and Kaplan, J. (2007) The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease. Blood 109, 4174-4180
31. Pietrangelo, A. (2004) The ferroportin disease. Blood Cells Mol. Dis. 32, 131-138
32. Chlosta, S., Fishman, D. S., Harrington, L., Johnson, E. E., Knutson, M. D., Wessling-Resnick, M., and Cherayil, B. J. (2006) The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infect. Immun. 74, 3065-3067
33. Lahousse, S. A., Carter, J. J., Xu, X. J., Wands, J. R., and de la Monte, S. M. (2006) Differential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells. BMC Cell Biol. 7, 41
34. Le, M. T., Xie, H., Zhou, B., Chia, P. H., Rizk, P., Um, M., Udolph, G., Yang, H., Lim, B., and Lodish, H. F. (2009) MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets. Mol. Cell. Biol. 29, 5290-5305
35. Liu, S., Zhang, S., Bromley-Brits, K., Cai, F., Zhou, W., Xia, K., Mittelholtz, J., and Song, W. (2011) Transcriptional Regulation of TMP21 by NFAT. Mol. Neurodegener. 6, 21
36. Yonashiro, R., Kimijima, Y., Shimura, T., Kawaguchi, K., Fukuda, T., Inatome, R., and Yanagi, S. (2012) Mitochondrial ubiquitin ligase MITOL blocks S-nitrosylated MAP1B-light chain 1-mediated mitochondrial dysfunction and neuronal cell death. Proc. Natl. Acad. Sci. USA 109, 2382-2387
37. Cao, C., Rioult-Pedotti, M. S., Migani, P., Yu, C. J., Tiwari, R., Parang, K., Spaller, M. R., Goebel, D. J., and Marshall, J. (2013) Impairment of TrkB-PSD-95 signaling in Angelman syndrome. PLoS Biol. 11, e1001478
38. Xie, L., Tiong, C. X., and Bian, J. S. (2012) Hydrogen sulfide protects SH-SY5Y cells against 6-hydroxydopamine-induced endoplasmic reticulum stress. Am. J. Physiol. Cell Physiol. 303, C81-C91
39. Soundararajan, R., Wishart, A. D., Rupasinghe, H. P., Arcellana-Panlilio, M., Nelson, C. M., Mayne, M., and Robertson, G. S. (2008) Quercetin 3-glucoside protects neuroblastoma (SH-SY5Y) cells in vitro against oxidative damage by inducing sterol regulatory element-binding protein-2-mediated cholesterol biosynthesis. J. Biol. Chem. 283, 2231-2245
40. Bertinchamps, A. J., Miller, S. T., and Cotzias, G. C. (1966) Interdependence of routes excreting manganese. Am. J. Physiol. 211, 217-224
41. Seo, Y. A., Li, Y., and Wessling-Resnick, M. (2013) Iron depletion increases manganese uptake and potentiates apoptosis through ER stress. Neurotoxicology 38, 67-73
42. Li, X., Xie, J., Lu, L., Zhang, L., Zhang, L., Zou, Y., Wang, Q., Luo, X., and Li, S. (2013) Kinetics of manganese transport and gene expressions of manganese transport carriers in Caco-2 cell monolayers. Biometals 26, 941-953
43. Finley, J. W., Johnson, P. E., and Johnson, L. K. (1994) Sex affects manganese absorption and retention by humans from a diet adequate in manganese. Am. J. Clin. Nutr. 60, 949-955
44. Bosomworth, H. J., Thornton, J. K., Coneyworth, L. J., Ford, D., and Valentine, R. A. (2012) Efflux function, tissue-specific expression and intracellular trafficking of the Zn transporter ZnT10 indicate roles in adult Zn homeostasis. Metallomics 4, 771-779
45. Ramey, G., Deschemin, J. C., Durel, B., Canonne-Hergaux, F., Nicolas, G., and Vaulont, S. (2010) Hepcidin targets ferroportin for degradation in hepatocytes. Haematologica 95, 501-504
46. Laftah, A. H., Sharma, N., Brookes, M. J., McKie, A. T., Simpson, R. J., Iqbal, T. H., and Tselepis, C. (2006) Tumour necrosis factor alpha causes hypoferraemia and reduced intestinal iron absorption in mice. Biochem. J. 397, 61-67
47. Thomas, C., and Oates, P. S. (2004) Ferroportin/IREG-1/MTP-1/SLC40A1 modulates the uptake of iron at the apical membrane of enterocytes. Gut 53, 44-49
48. Zumerle, S., Mathieu, J. R., Delga, S., Heinis, M., Viatte, L., Vaulont, S., and Peyssonnaux, C. (2014) Targeted disruption of hepcidin in the liver recapitulates the hemochromatotic phenotype. Blood 123, 3646-3650
49. Tussing-Humphreys, L., Pusatcioglu, C., Nemeth, E., and Braunschweig, C. (2012) Rethinking iron regulation and assessment in iron deficiency, anemia of chronic disease, and obesity: introducing hepcidin. J. Acad. Nutr. Diet. 112, 391-400
50. Erratum in J. Acad. Nutr. Diet. 2012;112:762
51. Ahmad, K. A., Ahmann, J. R., Migas, M. C., Waheed, A., Britton, R. S., Bacon, B. R., Sly, W. S., and Fleming, R. E. (2002) Decreased liver hepcidin expression in the Hfe knockout mouse. Blood Cells Mol. Dis. 29, 361-366
52. Piperno, A., Girelli, D., Nemeth, E., Trombini, P., Bozzini, C., Poggiali, E., Phung, Y., Ganz, T., and Camaschella, C. (2007) Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood 110, 4096-4100
53. Claus Henn, B., Kim, J., Wessling-Resnick, M., Téllez-Rojo, M. M., Jayawardene, I., Ettinger, A. S., Hernández-Avila, M., Schwartz, J., Christiani, D. C., Hu, H., and Wright, R. O. (2011) Associations of iron metabolism genes with blood manganese levels: a population-based study with validation data from animal models. Environ. Health 10, 97
54. Kim, J., Buckett, P. D., and Wessling-Resnick, M. (2013) Absorption of manganese and iron in a mouse model of hemochromatosis. PLoS ONE 8, e64944
55. Bartnikas, T. B. (2012) Known and potential roles of transferrin in iron biology. Biometals 25, 677-686
56. Roth, J. A., and Garrick, M. D. (2003) Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. Biochem. Pharmacol. 66, 1-13
57. Tjälve, H., Henriksson, J., Tallkvist, J., Larsson, B. S., and Lindquist, N. G. (1996) Uptake of manganese and cadmium from the nasal mucosa into the central nervous system via olfactory pathways in rats. Pharmacol. Toxicol. 79, 347-356
58. Brenneman, K. A., Wong, B. A., Buccellato, M. A., Costa, E. R., Gross, E. A., and Dorman, D. C. (2000) Direct olfactory transport of inhaled manganese ((54) MnCl (2)) to the rat brain: toxicokinetic investigations in a unilateral nasal occlusion model. Toxicol. Appl. Pharmacol. 169, 238-248
59. Nong, A., Teeguarden, J. G., Clewell III, H. J., Dorman, D. C., and Andersen, M. E. (2008) Pharmacokinetic modeling of manganese in the rat, IV: assessing factors that contribute to brain accumulation during inhalation exposure. J. Toxicol. Environ. Health A 71, 413-426
60. Knutson, M. D., Oukka, M., Koss, L. M., Aydemir, F., and Wessling-Resnick, M. (2005) Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc. Natl. Acad. Sci. USA 102, 1324-1328
61. Boserup, M. W., Lichota, J., Haile, D., and Moos, T. (2011) Heterogenous distribution of ferroportin-containing neurons in mouse brain. Biometals 24, 357-375
62. Pietrangelo, A., Caleffi, A., and Corradini, E. (2011) Non-HFE hepatic iron overload. Semin. Liver Dis. 31, 302-318
63. Guilarte, T. R. (2010) Manganese and Parkinson's disease: a critical review and new findings. Environ. Health Perspect. 118, 1071-1080
64. Racette, B. A., McGee-Minnich, L., Moerlein, S. M., Mink, J. W., Videen, T. O., and Perlmutter, J. S. (2001) Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology 56, 8-13